ShareHope Medicine Co., Ltd. (TPEX:8403)
24.95
0.00 (0.00%)
Sep 18, 2025, 1:30 PM CST
ShareHope Medicine Revenue
ShareHope Medicine had revenue of 1.07B TWD in the quarter ending June 30, 2025, a decrease of -1.74%. This brings the company's revenue in the last twelve months to 4.39B, up 6.97% year-over-year. In the year 2024, ShareHope Medicine had annual revenue of 4.33B with 11.68% growth.
Revenue (ttm)
4.39B
Revenue Growth
+6.97%
P/S Ratio
0.78
Revenue / Employee
37.17M
Employees
118
Market Cap
3.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
Dec 31, 2020 | 4.10B | 974.99M | 31.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lumosa Therapeutics | 37.25M |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |